These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 20083914)

  • 1. Antiphospholipid antibodies in critical illness.
    Dentali F; Crowther M
    Crit Care Med; 2010 Feb; 38(2 Suppl):S51-6. PubMed ID: 20083914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of antiphospholipid antibody syndrome: a systematic review.
    Lim W; Crowther MA; Eikelboom JW
    JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid syndrome.
    Gezer S
    Dis Mon; 2003 Dec; 49(12):696-741. PubMed ID: 14679358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid syndrome: an evolving story.
    Robertson B; Greaves M
    Blood Rev; 2006 Jul; 20(4):201-12. PubMed ID: 16442679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibiodies: a critical review of the literature.
    Lim W; Crowther MA
    Curr Opin Hematol; 2007 Sep; 14(5):494-9. PubMed ID: 17934356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of antiphospholipid syndrome-related thrombosis.
    Puente D; Pombo G; Forastiero R
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of thrombosis in the antiphospholipid-antibody syndrome.
    Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
    N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How much warfarin is enough in APS related thrombosis?
    Erkan D; Lockshin MD
    Thromb Res; 2004; 114(5-6):435-42. PubMed ID: 15507275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
    Crowther MA; Ginsberg JS; Julian J; Denburg J; Hirsh J; Douketis J; Laskin C; Fortin P; Anderson D; Kearon C; Clarke A; Geerts W; Forgie M; Green D; Costantini L; Yacura W; Wilson S; Gent M; Kovacs MJ
    N Engl J Med; 2003 Sep; 349(12):1133-8. PubMed ID: 13679527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.
    Krnic-Barrie S; O'Connor CR; Looney SW; Pierangeli SS; Harris EN
    Arch Intern Med; 1997 Oct; 157(18):2101-8. PubMed ID: 9382667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the neurological manifestations of APS--what do the trials tell us?
    Brey RL
    Thromb Res; 2004; 114(5-6):489-99. PubMed ID: 15507283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis.
    Crowther MA; Wisloff F
    Thromb Res; 2005; 115(1-2):3-8. PubMed ID: 15567446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of antiphospholipid syndrome.
    Tuthill JI; Khamashta MA
    J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid syndrome.
    Erkan D; Lockshin MD
    Curr Opin Rheumatol; 2006 May; 18(3):242-8. PubMed ID: 16582686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards evidence-based treatment of thrombotic antiphospholipid syndrome.
    Derksen RH; de Groot PG
    Lupus; 2010 Apr; 19(4):470-4. PubMed ID: 20353990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for venous thromboembolism in children.
    Gerotziafas GT
    Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ischemic stroke with antiphospholipid antibody].
    Kitagawa Y; Ohkuma H; Tokuoka K
    Brain Nerve; 2008 Oct; 60(10):1144-58. PubMed ID: 18975602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors.
    Espinosa G; Bucciarelli S; Asherson RA; Cervera R
    Semin Thromb Hemost; 2008 Apr; 34(3):290-4. PubMed ID: 18720310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular events in patients with antiphospholipid antibodies: strategies of prevention.
    Tufano A; Guida A; Di Minno MN; De Gregorio AM; Cerbone AM; Di Minno G
    Nutr Metab Cardiovasc Dis; 2010 May; 20(4):217-23. PubMed ID: 20153613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.